Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.

CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

Ultrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving ...

Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...

“Bev has significant kyphoscoliosis (curvature of the spine that’s both sideways and forward/backward), which made the biopsy ...

Tarlatamaba, a new treatment for adult patients with SCLC, has been approved by the Medicines and Healthcare Products ...

Amgen's Imdylltra gets MHRA nod for ES-SCLC after two prior therapies, offering new hope for aggressive cancer with limited ...

Acasunlimab is under clinical development by BioNTech and currently in Phase III for Non-Small Cell Lung Cancer.

The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...